PTSD red flags and safety concerns¶
TL;DR — PTSD is associated with suicide risk, substance-related harm, functional impairment and exposure to ongoing violence; acute safety assessment takes priority over protocol completion. Trauma-focused treatment can temporarily increase distress, but systematic adverse-event reporting is sparse and symptom activation is not synonymous with lasting harm (Cusack 2016, PMID 26574151). Severe dissociation, intoxication/withdrawal, psychosis/mania, unstable medical conditions and ongoing coercion require assessment and adaptation. This page is a research safety map, not emergency or individual medical advice.
Immediate priorities¶
Imminent suicide risk, homicide risk, severe self-neglect, intoxication/withdrawal, psychosis/mania, acute neurologic change and ongoing violence require urgent local assessment. A PTSD label does not explain away these states.
Suicide¶
Associations between PTSD and suicide may be mediated or modified by depression, SUD, pain, dissociation, social loss and access to lethal means. Risk is dynamic; population association is not individual prediction (Sher 2010, PMID 20662745) (Kalin 2023, PMID 37777853).
Exposure-related distress¶
Short-term distress during trauma processing is expected for some patients. The key safety outcomes are sustained worsening, self-harm, loss of function, dangerous coping and dropout—not a transient session rating (Cusack 2016, PMID 26574151).
Dissociation¶
Dissociation can impair engagement, memory continuity and risk detection. It should be measured rather than used as an automatic exclusion; grounding, pacing and stabilization may be individualized (Ford 2015, PMID 25760316).
Ongoing trauma¶
Therapy cannot make an unsafe environment safe. Safeguarding, housing, legal/advocacy resources and practical protection may be prerequisites or concurrent needs.
Medication and substances¶
Blood-pressure effects matter with adrenergic drugs; prazosin lowered supine systolic pressure by 6.7 mm Hg versus placebo in PACT (Raskind 2018, PMID 29414272). Alcohol/benzodiazepine withdrawal and drug interactions require medical management.
Boundaries in drug-assisted therapy¶
MDMA protocols intensify power, suggestibility and physical proximity concerns, and the reviews that recount the FDA's 2024 decision list inadequate safety monitoring alongside blinding failure and missing active comparators among the methodological problems the programme has to solve (Wolfgang 2025, PMID 39741438) (Morland 2026, PMID 41820235). Independent monitoring, consent, chaperoning/boundary rules and complaint pathways are safety mechanisms, not optional extras.
Children¶
Safeguarding and caregiver involvement must be separated when the caregiver may be implicated. Adult medication approvals cannot be imported: the NICE guideline's dedicated evidence review of pharmacological interventions for the prevention and treatment of PTSD in children is a separate review from the adult drug evidence (National Guideline Alliance 2018, PMID 32757557), and the pediatric drug trials that exist are small — a 26-child randomized trial of sertraline after burns found benefit on parent-reported but not child-reported symptoms (Stoddard 2011, PMID 22040192). The pediatric treatment evidence that is strong is psychological: 70 RCTs and 5,528 patients in the pediatric network meta-analysis, against no comparable pediatric drug network (Hoppen 2025, PMID 39630422).
Reporting standard¶
Trials should preregister adverse events, serious adverse events, symptom worsening, suicidality, abuse/misconduct, hospitalization and reasons for withdrawal by arm.
Quantitative anchors¶
| Measure | Estimate | Population/method | Source |
|---|---|---|---|
| Psychotherapy review | 64 trials | Adverse-event data absent from most studies | (Cusack 2016, PMID 26574151) |
| Prazosin re-test suicidal ideation | 8% vs 15% | New/worsening; prazosin vs placebo | (Raskind 2018, PMID 29414272) |
| Pediatric NMA | 70 RCTs; n=5,528 | Counters claim TF-CBT is generally harmful | (Hoppen 2025, PMID 39630422) |
| Pediatric sertraline after burns | benefit on parent- but not child-reported symptoms | n=26 (17 sertraline, 9 placebo) | (Stoddard 2011, PMID 22040192) |
| Pediatric drug evidence base | separate NICE evidence review from adult drug evidence | Guideline evidence review E | (National Guideline Alliance 2018, PMID 32757557) |
Evidence ledger¶
The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.
| PMID | Year | Evidence contribution | Scope caution |
|---|---|---|---|
| 26574151 | 2016 | Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 29414272 | 2018 | Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. | PTSD-specific record; inspect design and population |
| 39630422 | 2025 | Psychological Interventions for Pediatric Posttraumatic Stress Disorder: A Systematic Review and Network Meta-Analysis. | Synthesis: preserve included-population and certainty limits |
| 37777853 | 2023 | Stress, Heritability, and Genetic Factors Influencing Depression, PTSD, and Suicidal Behavior. | PTSD-specific record; inspect design and population |
| 20662745 | 2010 | Neurobiology of suicidal behavior in post-traumatic stress disorder. | PTSD-specific record; inspect design and population |
| 25760316 | 2015 | Self-injury and suicidality: the impact of trauma and dissociation. | PTSD-specific record; inspect design and population |
| 36265258 | 2022 | Trauma, historical trauma, PTSD and suicide in an American Indian community sample. | PTSD-specific record; inspect design and population |
| 23995037 | 2013 | Posttraumatic stress disorder and suicide risk among veterans: a literature review. | Synthesis: preserve included-population and certainty limits |
| 37052115 | 2023 | Depression, PTSD, and suicidal ideation among ex-ultra-Orthodox individuals in Israel. | PTSD-specific record; inspect design and population |
| 36385705 | 2023 | Posttraumatic stress disorder and risk of suicidal behavior: A systematic review and meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 39719633 | 2024 | Depression, post-traumatic stress disorder, suicidal ideation and ketamine: a case report. | PTSD-specific record; inspect design and population |
| 20940670 | 2010 | Suicidal behavior in adolescents with post-traumatic stress disorder. | PTSD-specific record; inspect design and population |
| 37679519 | 2023 | Moral Injury is a Risk Factor for Substance Use and Suicidality Among US Military Veterans with and without Traumatic Brain Injury. | PTSD-specific record; inspect design and population |
| 39173901 | 2024 | Editorial: The Risks of Suicidality and Self-Harm in Adolescents During War: A Global Research Priority. | PTSD-specific record; inspect design and population |
| 36201968 | 2022 | Frequency and correlates of suicidal ideation and behaviors in treatment-seeking Post-9/11 Veterans. | PTSD-specific record; inspect design and population |
| 37226725 | 2023 | Sexual Assault, Posttraumatic Stress, Alcohol Use, and Suicidality Among Diverse College Students. | PTSD-specific record; inspect design and population |
| 27314245 | 2016 | Treating PTSD Within the Context of Heightened Suicide Risk. | PTSD-specific record; inspect design and population |
| 37073774 | 2024 | Posttraumatic Stress Disorder, Suicidal ideation, and Stress: The Moderating Role of Dysfunctional and Recovery Cognitions. | PTSD-specific record; inspect design and population |
| 38032627 | 2024 | Predicting suicidal ideation 3 months following intensive posttraumatic stress disorder treatment. | PTSD-specific record; inspect design and population |
| 38382625 | 2024 | Functional connectivity alterations in PTSD patients with suicidal ideation. | PTSD-specific record; inspect design and population |
| 35262616 | 2022 | Suicide attempt, impulsivity, and exposure to trauma in college students. | PTSD-specific record; inspect design and population |
| 25398198 | 2015 | Suicidality and posttraumatic stress disorder (PTSD) in adolescents: a systematic review and meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 37143334 | 2023 | Diagnosed Posttraumatic Stress Disorder and Other Trauma-Associated Stress Disorders and Risk for Suicide Mortality. | PTSD-specific record; inspect design and population |
| 32741212 | 2021 | Suicide risk among persons living with HIV. | PTSD-specific record; inspect design and population |
| 29594718 | 2018 | Suicidality in Subjects With Anxiety or Obsessive-Compulsive and Related Disorders: Recent Advances. | Pooled/cross-disorder: use only an explicit PTSD stratum |
| 32248664 | 2020 | Religion, spirituality, and suicide risk in Iraq and Afghanistan era veterans. | PTSD-specific record; inspect design and population |
| 38174625 | 2024 | Associations among posttraumatic stress disorder symptoms, suicidal ideation, suicide attempts, and reward discounting. | PTSD-specific record; inspect design and population |
| 39741438 | 2025 | MDMA and MDMA-Assisted Therapy. | PTSD-specific record; inspect design and population |
| 22040192 | 2011 | A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children. | n=26; informant discordance |
| 32757557 | 2018 | Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review E. | Guideline evidence review, not a primary study |
| 41820235 | 2026 | State of the Science: MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder. | Narrative review; records the August 2024 FDA decision |
Interpretation guardrails¶
- Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
- A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
- Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
- Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
- Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
- This page synthesizes research and does not provide individual medical advice.
Minimum extraction frame for studies on this topic¶
| Field | What must be retained | Why it changes interpretation |
|---|---|---|
| Diagnostic system | DSM version, ICD version, full/subthreshold | Case mix is not interchangeable |
| Diagnostic method | Structured interview, clinician judgment, self-report cutoff | Screening is not diagnosis |
| Index trauma | Type, timing, repetition, direct/indirect/occupational | Conditional risk and phenotype differ |
| Population | Civilian, veteran, refugee, child/adolescent, mixed | Transportability is empirical |
| Baseline severity | Mean, SD, range and exclusion threshold | Ceiling and floor effects alter change |
| CPTSD status | ITQ/ICD-11 definition and DSO score | Complexity cannot be inferred from trauma count |
| Comorbidity | Depression, GAD, SUD, pain, TBI measured separately | Shared symptoms can distort effects |
| Comparator | Waitlist, usual care, attention, active treatment | The estimand changes with comparator |
| Treatment dose | Sessions offered/attended, duration, homework | Assignment is not exposure |
| Outcome | Symptoms, diagnosis, response, function, sleep | Outcomes are not interchangeable |
| Time point | End point and prespecified follow-up windows | Acute benefit may not persist |
| Missing data | Denominator, reasons, imputation and estimand | Attrition can bias rank and magnitude |
| Adverse events | Definitions, ascertainment and arm-level counts | Absence of reporting is not absence of harm |
| Therapist/context | Training, fidelity, allegiance, setting | Delivery is part of the intervention |
| Funding/conflicts | Sponsor role and analytic independence | Especially material for proprietary packages |
Claims this page does not make¶
- It does not infer PTSD from trauma exposure alone.
- It does not treat a self-report cutoff as equivalent to a structured diagnosis.
- It does not convert a pooled anxiety-disorder effect into a PTSD effect.
- It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
- It does not infer superiority from a statistically significant within-group change.
- It does not infer equivalence from a non-significant between-group test.
- It does not infer effectiveness from trial registration or mechanistic plausibility.
- It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
- It does not average conflicting estimates that use different definitions.
- It does not treat lack of adverse-event reporting as evidence of safety.
Evidence-updating triggers¶
| Trigger | Required response |
|---|---|
| New diagnostic revision | Recalculate which populations prior estimates represent |
| New head-to-head RCT | Compare against active treatment, not only waitlist |
| New individual-participant synthesis | Revisit effect modifiers and transportability |
| Registry status change | Verify results and linked publication before changing conclusions |
| Guideline update | Separate evidence review from panel recommendation |
| Regulatory decision | Record decision date and source; do not infer from efficacy papers |
| Safety signal | Re-extract denominator, ascertainment and exposure time by arm |
| Contradictory replication | Display estimates side by side; do not average definitions |
Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.
Open questions¶
- What standard adverse-event taxonomy should every PTSD psychotherapy trial use? (Cusack 2016, PMID 26574151)
- Which dissociation patterns predict need for adaptation rather than exclusion? (Ford 2015, PMID 25760316)
- How can drug-assisted therapy independently monitor therapist-boundary harms? (Wolfgang 2025, PMID 39741438)
Related pages¶
- dropout-and-nonresponse — discontinuation and worsening.
- mdma-and-psychedelic-assisted-therapy — boundary and medical risks.
- sleep-and-nightmare-treatment — adrenergic safety.
- children-and-adolescents — safeguarding.
References¶
- Cusack K, et al. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2016;43:128-41. PMID 26574151
- Raskind MA, et al. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med. 2018;378(6):507-517. PMID 29414272
- Hoppen TH, et al. Psychological Interventions for Pediatric Posttraumatic Stress Disorder: A Systematic Review and Network Meta-Analysis. JAMA Psychiatry. 2025;82(2):130-141. PMID 39630422
- Kalin NH Stress, Heritability, and Genetic Factors Influencing Depression, PTSD, and Suicidal Behavior. Am J Psychiatry. 2023;180(10):699-702. PMID 37777853
- Sher L Neurobiology of suicidal behavior in post-traumatic stress disorder. Expert Rev Neurother. 2010;10(8):1233-5. PMID 20662745
- Ford JD, et al. Self-injury and suicidality: the impact of trauma and dissociation. J Trauma Dissociation. 2015;16(3):225-31. PMID 25760316
- Ehlers CL, et al. Trauma, historical trauma, PTSD and suicide in an American Indian community sample. J Psychiatr Res. 2022;156:214-220. PMID 36265258
- Pompili M, et al. Posttraumatic stress disorder and suicide risk among veterans: a literature review. J Nerv Ment Dis. 2013;201(9):802-12. PMID 23995037
- Levi-Belz Y, et al. Depression, PTSD, and suicidal ideation among ex-ultra-Orthodox individuals in Israel. Eur J Psychotraumatol. 2023;14(1):2172259. PMID 37052115
- Akbar R, et al. Posttraumatic stress disorder and risk of suicidal behavior: A systematic review and meta-analysis. Suicide Life Threat Behav. 2023;53(1):163-184. PMID 36385705
- Asad S, et al. Depression, post-traumatic stress disorder, suicidal ideation and ketamine: a case report. J Med Case Rep. 2024;18(1):638. PMID 39719633
- Ganz D, et al. Suicidal behavior in adolescents with post-traumatic stress disorder. Minerva Pediatr. 2010;62(4):363-70. PMID 20940670
- McDaniel JT, et al. Moral Injury is a Risk Factor for Substance Use and Suicidality Among US Military Veterans with and without Traumatic Brain Injury. J Relig Health. 2023;62(6):3926-3941. PMID 37679519
- Amone-P'Olak K Editorial: The Risks of Suicidality and Self-Harm in Adolescents During War: A Global Research Priority. J Am Acad Child Adolesc Psychiatry. 2024;63(12):1199-1200. PMID 39173901
- Rauch SAM, et al. Frequency and correlates of suicidal ideation and behaviors in treatment-seeking Post-9/11 Veterans. J Psychiatr Res. 2022;155:559-566. PMID 36201968
- Gilmore AK, et al. Sexual Assault, Posttraumatic Stress, Alcohol Use, and Suicidality Among Diverse College Students. J Interpers Violence. 2023;38(19-20):10588-10610. PMID 37226725
- Bryan CJ Treating PTSD Within the Context of Heightened Suicide Risk. Curr Psychiatry Rep. 2016;18(8):73. PMID 27314245
- Gomes KD, et al. Posttraumatic Stress Disorder, Suicidal ideation, and Stress: The Moderating Role of Dysfunctional and Recovery Cognitions. Arch Suicide Res. 2024;28(2):569-584. PMID 37073774
- Smith DL, et al. Predicting suicidal ideation 3 months following intensive posttraumatic stress disorder treatment. Psychol Trauma. 2024;16(Suppl 3):S547-S554. PMID 38032627
- Wood S, et al. Functional connectivity alterations in PTSD patients with suicidal ideation. Brain Res Bull. 2024;209:110905. PMID 38382625
- Lira SB, et al. Suicide attempt, impulsivity, and exposure to trauma in college students. Braz J Psychiatry. 2022;44(3):279-288. PMID 35262616
- Panagioti M, et al. Suicidality and posttraumatic stress disorder (PTSD) in adolescents: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2015;50(4):525-37. PMID 25398198
- Sala-Hamrick KJ, et al. Diagnosed Posttraumatic Stress Disorder and Other Trauma-Associated Stress Disorders and Risk for Suicide Mortality. Psychiatr Serv. 2023;74(9):936-942. PMID 37143334
- Brown LA, et al. Suicide risk among persons living with HIV. AIDS Care. 2021;33(5):616-622. PMID 32741212
- De La Vega D, et al. Suicidality in Subjects With Anxiety or Obsessive-Compulsive and Related Disorders: Recent Advances. Curr Psychiatry Rep. 2018;20(4):26. PMID 29594718
- Smigelsky MA, et al. Religion, spirituality, and suicide risk in Iraq and Afghanistan era veterans. Depress Anxiety. 2020;37(8):728-737. PMID 32248664
- McManimen SL, et al. Associations among posttraumatic stress disorder symptoms, suicidal ideation, suicide attempts, and reward discounting. Stress Health. 2024;40(4):e3370. PMID 38174625
- Wolfgang AS, et al. MDMA and MDMA-Assisted Therapy. Am J Psychiatry. 2025;182(1):79-103. PMID 39741438
- Stoddard FJ Jr, et al. A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children. J Child Adolesc Psychopharmacol. 2011;21(5):469-77. PMID 22040192
- National Guideline Alliance (UK). Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review E. London: NICE; 2018. PMID 32757557
- Morland LA, et al. State of the Science: MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder. J Trauma Stress. 2026;39(2):173-187. PMID 41820235